Quantification of fundus auto-fluorescence (qAF) in recessive Stargardt’s disease (STGD1) patients may contribute to improved outcome measures for clinical trials
Joint research conducted between the Departments of Ophthalmology at Columbia University, New York and Harvard Medical School, Massachusetts has shown that a novel methodology for… Read More »Quantification of fundus auto-fluorescence (qAF) in recessive Stargardt’s disease (STGD1) patients may contribute to improved outcome measures for clinical trials